Cargando…
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
The objective of this subset analysis was to evaluate and compare the efficacy and tolerability of two combination treatments for men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Data were from a real-world, open-label, prospective, an...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267652/ https://www.ncbi.nlm.nih.gov/pubmed/35806900 http://dx.doi.org/10.3390/jcm11133615 |
_version_ | 1784743784772272128 |
---|---|
author | Alcaraz, Antonio Castro-Díaz, David Gacci, Mauro Salonia, Andrea Ficarra, Vincenzo Carballido-Rodríguez, Joaquín Rodríguez-Antolín, Alfredo Medina-Polo, José Fernández-Gómez, Jesús M. Cózar-Olmo, José M. Búcar-Terrades, Santiago Pérez-León, Noemí Brenes-Bermúdez, Francisco J. Molero-García, José M. Fernández-Pro-Ledesma, Antonio Herdman, Michael Angulo, Javier C. Manasanch, José |
author_facet | Alcaraz, Antonio Castro-Díaz, David Gacci, Mauro Salonia, Andrea Ficarra, Vincenzo Carballido-Rodríguez, Joaquín Rodríguez-Antolín, Alfredo Medina-Polo, José Fernández-Gómez, Jesús M. Cózar-Olmo, José M. Búcar-Terrades, Santiago Pérez-León, Noemí Brenes-Bermúdez, Francisco J. Molero-García, José M. Fernández-Pro-Ledesma, Antonio Herdman, Michael Angulo, Javier C. Manasanch, José |
author_sort | Alcaraz, Antonio |
collection | PubMed |
description | The objective of this subset analysis was to evaluate and compare the efficacy and tolerability of two combination treatments for men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Data were from a real-world, open-label, prospective, and multicenter study performed in outpatient urology clinics. Men with moderate-to-severe LUTS/BPH received 6-month treatment with tamsulosin (TAM) in combination with either the hexanic extract of S. repens (HESr) or a 5-alpha-reductase inhibitor (5ARI). Changes in urinary symptoms and quality of life were measured using the IPSS and BII questionnaires, respectively. Treatment tolerability was assessed by recording adverse effects (AEs). Patients in the two study groups were matched using iterative and propensity score matching approaches. After iterative matching, data were available from 136 patients (n = 68 treated with TAM + 5ARI, n = 68 with TAM + HESr). After 6 months of treatment, mean (SD) IPSS total score improved by 7.7 (6.3) and 6.7 (5.0) points in the TAM + 5ARI and TAM + HESr groups, respectively (p = 0.272); mean BII total scores improved by 3.1 (2.9) and 2.9 (2.4) points (p = 0.751), respectively. AEs were reported by 26.5% and 10.3% of patients in the same groups, mostly affecting sexual function (p < 0.027). When used in a real-world setting to treat patients with moderate-severe LUTS/BPH, 6-month treatment with TAM + HESr was as effective as TAM + 5ARI, but with better tolerability. |
format | Online Article Text |
id | pubmed-9267652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92676522022-07-09 Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study Alcaraz, Antonio Castro-Díaz, David Gacci, Mauro Salonia, Andrea Ficarra, Vincenzo Carballido-Rodríguez, Joaquín Rodríguez-Antolín, Alfredo Medina-Polo, José Fernández-Gómez, Jesús M. Cózar-Olmo, José M. Búcar-Terrades, Santiago Pérez-León, Noemí Brenes-Bermúdez, Francisco J. Molero-García, José M. Fernández-Pro-Ledesma, Antonio Herdman, Michael Angulo, Javier C. Manasanch, José J Clin Med Article The objective of this subset analysis was to evaluate and compare the efficacy and tolerability of two combination treatments for men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Data were from a real-world, open-label, prospective, and multicenter study performed in outpatient urology clinics. Men with moderate-to-severe LUTS/BPH received 6-month treatment with tamsulosin (TAM) in combination with either the hexanic extract of S. repens (HESr) or a 5-alpha-reductase inhibitor (5ARI). Changes in urinary symptoms and quality of life were measured using the IPSS and BII questionnaires, respectively. Treatment tolerability was assessed by recording adverse effects (AEs). Patients in the two study groups were matched using iterative and propensity score matching approaches. After iterative matching, data were available from 136 patients (n = 68 treated with TAM + 5ARI, n = 68 with TAM + HESr). After 6 months of treatment, mean (SD) IPSS total score improved by 7.7 (6.3) and 6.7 (5.0) points in the TAM + 5ARI and TAM + HESr groups, respectively (p = 0.272); mean BII total scores improved by 3.1 (2.9) and 2.9 (2.4) points (p = 0.751), respectively. AEs were reported by 26.5% and 10.3% of patients in the same groups, mostly affecting sexual function (p < 0.027). When used in a real-world setting to treat patients with moderate-severe LUTS/BPH, 6-month treatment with TAM + HESr was as effective as TAM + 5ARI, but with better tolerability. MDPI 2022-06-22 /pmc/articles/PMC9267652/ /pubmed/35806900 http://dx.doi.org/10.3390/jcm11133615 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alcaraz, Antonio Castro-Díaz, David Gacci, Mauro Salonia, Andrea Ficarra, Vincenzo Carballido-Rodríguez, Joaquín Rodríguez-Antolín, Alfredo Medina-Polo, José Fernández-Gómez, Jesús M. Cózar-Olmo, José M. Búcar-Terrades, Santiago Pérez-León, Noemí Brenes-Bermúdez, Francisco J. Molero-García, José M. Fernández-Pro-Ledesma, Antonio Herdman, Michael Angulo, Javier C. Manasanch, José Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study |
title | Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study |
title_full | Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study |
title_fullStr | Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study |
title_full_unstemmed | Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study |
title_short | Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study |
title_sort | efficacy and tolerability of 6-month treatment with tamsulosin plus the hexanic extract of serenoa repens versus tamsulosin plus 5-alpha-reductase inhibitors for moderate-to-severe luts-bph patients: results of a paired matched clinical study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267652/ https://www.ncbi.nlm.nih.gov/pubmed/35806900 http://dx.doi.org/10.3390/jcm11133615 |
work_keys_str_mv | AT alcarazantonio efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT castrodiazdavid efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT gaccimauro efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT saloniaandrea efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT ficarravincenzo efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT carballidorodriguezjoaquin efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT rodriguezantolinalfredo efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT medinapolojose efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT fernandezgomezjesusm efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT cozarolmojosem efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT bucarterradessantiago efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT perezleonnoemi efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT brenesbermudezfranciscoj efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT molerogarciajosem efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT fernandezproledesmaantonio efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT herdmanmichael efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT angulojavierc efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT manasanchjose efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy AT efficacyandtolerabilityof6monthtreatmentwithtamsulosinplusthehexanicextractofserenoarepensversustamsulosinplus5alphareductaseinhibitorsformoderatetoseverelutsbphpatientsresultsofapairedmatchedclinicalstudy |